XPH: Small-Cap Pharma Turns Higher, At Long Last

XPH offers diversified exposure to large-, mid-, and small-cap pharma stocks, balancing blue-chip stalwarts and speculative ...

MDY: Its Focus On Profitability Hasn't Paid Off Lately (Rating Downgrade)

MDY has underperformed major indices, returning just 2.6% since October 2024 and lagging the S&P 500 by 12 percentage points.
Investopedia

Yield Curve: What It Is, How It Works, and Types

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...